Staar Surgical Co [STAA] stock is trading at $17.40, up 1.34%. An important factor to consider is whether the stock is rising or falling in short-term value. The STAA shares have gain 5.33% over the last week, with a monthly amount drifted -2.08%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Staar Surgical Co [NASDAQ: STAA] stock has seen the most recent analyst activity on April 21, 2025, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $17. Previously, William Blair downgraded its rating to Mkt Perform on February 12, 2025. On February 12, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $17 on the stock. Jefferies downgraded its rating to a Hold. BTIG Research downgraded its rating to a Neutral. Morgan Stanley downgraded its rating to Underweight for this stock on July 15, 2024, and downed its price target to $37. In a note dated June 11, 2024, BTIG Research upgraded an Buy rating on this stock but restated the target price of $46.
Staar Surgical Co [STAA] stock has fluctuated between $13.50 and $49.86 over the past year. Currently, Wall Street analysts expect the stock to reach $54.58 within the next 12 months. Staar Surgical Co [NASDAQ: STAA] shares were valued at $17.40 at the most recent close of the market. An investor can expect a potential return of 213.68% based on the average STAA price forecast.
Analyzing the STAA fundamentals
Staar Surgical Co [NASDAQ:STAA] reported sales of 313.90M for the trailing twelve months, which represents a drop of -35.82%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 27.45, Equity is 0.05 and Total Capital is -28.71. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.07 points at the first support level, and at 16.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.93, and for the 2nd resistance point, it is at 18.47.
Ratios To Look Out For
For context, Staar Surgical Co’s Current Ratio is 5.23. On the other hand, the Quick Ratio is 4.62, and the Cash Ratio is 2.05. Considering the valuation of this stock, the price to sales ratio is 2.70, the price to book ratio is 2.16.
Transactions by insiders
Recent insider trading involved BROADWOOD PARTNERS, L.P., 10% Owner, that happened on Apr 08 ’25 when 0.18 million shares were purchased. 10% Owner, BROADWOOD PARTNERS, L.P. completed a deal on Apr 09 ’25 to buy 8200.0 shares. Meanwhile, 10% Owner BROADWOOD PARTNERS, L.P. bought 900.0 shares on Apr 10 ’25.